Quick Answer
GUIDED THERAPEUTICS INC reported Shares Outstanding of 86.15 million shares for fiscal year 2025.
GUIDED THERAPEUTICS INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 86.15M | +32.3% |
| 2024 | 65.13M | +20.4% |
| 2023 | 54.10M | +11.3% |
| 2022 | 48.60M | +255.4% |
| 2021 | 13.67M | +4.1% |
| 2020 | 13.14M | +395742.1% |
| 2019 | 3,319 | +24.4% |
| 2018 | 2,669 | -95.7% |
| 2017 | 61,954 | +9160.7% |
| 2016 | 669 | +22200.0% |
| 2015 | 3 | -100.0% |
| 2014 | 96,889 | +37.5% |
| 2013 | 70,479 | +13.2% |
| 2012 | 62,282 | +19.3% |
| 2011 | 52,211 | +10.4% |
| 2010 | 47,299 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 83.60M | +38.3% | +5.9% |
| June 30, 2025 | 78.97M | +46.0% | +1.3% |
| March 31, 2025 | 77.97M | +40.2% | +19.7% |
| December 31, 2024 | 65.13M | +20.4% | +7.7% |
| September 30, 2024 | 60.46M | +16.2% | +11.7% |
| June 30, 2024 | 54.10M | +6.1% | -2.7% |
| March 31, 2024 | 55.61M | +9.4% | +2.8% |
| December 31, 2023 | 54.10M | +11.3% | +4.0% |
- GUIDED THERAPEUTICS INC showed an increase of +32.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, GUIDED THERAPEUTICS INC’s shares outstanding has grown by 182047.6% (from 47.3 thousand shares to 86.15 million shares).
- The most recent figure is from GUIDED THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: